Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia ; volume:6 ; number:4 ; year:2020 ; pages:299-308
Kidney diseases ; 6, Heft 4 (2020), 299-308
- Creator
-
Ohki, Kohji
Wakui, Hiromichi
Uneda, Kazushi
Azushima, Kengo
Haruhara, Kotaro
Kinguchi, Sho
Urate, Shingo
Yamada, Takayuki
Yamaji, Takahiro
Kobayashi, Ryu
Kanaoka, Tomohiko
Minegishi, Shintaro
Ishigami, Tomoaki
Fujikawa, Tetsuya
Toya, Yoshiyuki
Tamura, Kouichi
- DOI
-
10.1159/000507396
- URN
-
urn:nbn:de:101:1-2020073000302610939125
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ohki, Kohji
- Wakui, Hiromichi
- Uneda, Kazushi
- Azushima, Kengo
- Haruhara, Kotaro
- Kinguchi, Sho
- Urate, Shingo
- Yamada, Takayuki
- Yamaji, Takahiro
- Kobayashi, Ryu
- Kanaoka, Tomohiko
- Minegishi, Shintaro
- Ishigami, Tomoaki
- Fujikawa, Tetsuya
- Toya, Yoshiyuki
- Tamura, Kouichi
Other Objects (12)
Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Effect of erythropoietin-stimulating agent on uremic inflammation
Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients with Non-Dialysis-Dependent Chronic Kidney Disease (RADIANCE-CKD Study)
Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease
Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)
Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study
Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
A systematic review and meta-analysis of factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents
Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Effect of erythropoietin-stimulating agent on uremic inflammation
Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients with Non-Dialysis-Dependent Chronic Kidney Disease (RADIANCE-CKD Study)
Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease
Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)
Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study
Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
A systematic review and meta-analysis of factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents
Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials
Tips for erythropoiesis-stimulating agent treatment of renal anemia
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort study
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Effect of erythropoietin-stimulating agent on uremic inflammation
Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients with Non-Dialysis-Dependent Chronic Kidney Disease (RADIANCE-CKD Study)
Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease
Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)
Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study
Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
A systematic review and meta-analysis of factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents
Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials
Tips for erythropoiesis-stimulating agent treatment of renal anemia